Federal Contractor Profile
The Univeristy Of Texas M.d. Anderson Cancer Center
$134M obligated·143 awards·4 agencies·21 NAICS
Federal Contracts
Showing award actions 51–100 of 178 funded award actions, most recent first.
- Contracts with positive obligations
- 143
- Funded award actions shown
- 178
- Obligations shown
- $134M
- Awarding agencies
- 4
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of September 10, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Oct 25, 2022 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018321P0463 | 811219 | MD ANDERSON TLD TEST - RADIOTHERAPY BEAMS MONITORING | $3K |
| Sep 28, 2022 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018322P0003 | 813920 | MD ANDERSON - IROC AUDIT - QUALITY AUDIT PROGRAM MEMBERSHIP. | $750 |
| Sep 21, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98022F00004 | 112990 | PER DIEM AND TESTING OF THE NIAID OWL MONKEY COLONY | $190K |
| Sep 16, 2022 | Department of Health and Human ServicesHRSA HEADQUARTERS | 75R60219C00004 | 621991 | NATIONAL CORD BLOOD INVENTORY | $8.6M |
| Sep 9, 2022 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40122P00381 | 541715 | A STUDY IN WHICH TWELVE BABOONS THAT HAVE RECOVERED FROM B. PERTUSSIS INFECTION WILL BE HOUSED AND FOLLOWED FOR ONE YEAR IN ORDER TO ASSESS DURATION OF B. PERTUSSIS IMMUNE RESPONSES. | $143K |
| Sep 8, 2022 | Department of Health and Human ServicesNIH NCI | 75N91022F00002 | 541714 | TARGETING STAT3 TO PREVENT NON-SMALL CELL LUNG CANCER (NSCLC) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | $1.1M |
| Aug 25, 2022 | Department of Health and Human ServicesNIH NCI | 75N91019F00129 | 541712 | OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH | $261K |
| Aug 5, 2022 | Department of Veterans Affairs245-NETWORK CONTRACT OFFICE 5 (36C245) | 36C24521C0180 | 541990 | MEDICAL PHYSICS PEER REVIEW OF RADIATION THERAPY QUALITY ASSURANCE OPERATIONS | $342K |
| Aug 5, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NLM | 75N97021C00001 | 541940 | OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | $550K |
| Aug 3, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98022F00003 | 112990 | SQUIRREL MONKEYS, SPF, 4 FEMALES, 8 MALE, GREATER THAN 750 GRAMS, IAW RFQ NID3 (75N98021D00018) | $41K |
| Jul 16, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98022F00002 | 112990 | RHESUS, INDIAN ORIGIN, EVEN GENDER, - 2 YRS OF AGE, SPF IAW RFQ NC42. (75N98021D00018) | $256K |
| May 24, 2022 | Department of Health and Human ServicesNIH NCI | 75N91022F00001 | 541714 | PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS-- TARGETING THE PARP PATHWAY FOR THE PREVENTION OF BREAST CANCER | $1.1M |
| May 20, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98022F00001 | 112990 | PER DIEM AND TESTING COST FOR THE NIAID OWL MONKEY COLONY | $70K |
| May 10, 2022 | Department of Health and Human ServicesHRSA HEADQUARTERS | 75R60219C00004 | 621991 | NATIONAL CORD BLOOD INVENTORY | $557K |
| Nov 30, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NLM | 75N97021C00001 | 541940 | OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | $1.0M |
| Sep 28, 2021 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40121C00180 | 541720 | IMMUNOGENICITY STUDY IN BABOONS FOLLOWING VACCINATION WITH EXPERIMENTAL ACELLULAR PERTUSSIS VACCINES. | $273K |
| Sep 27, 2021 | Department of Veterans Affairs245-NETWORK CONTRACT OFFICE 5 (36C245) | 36C24521C0180 | 541990 | MEDICAL PHYSICS PEER REVIEW OF RADIATION THERAPY QUALITY ASSURANCE OPERATIONS | $321K |
| Sep 24, 2021 | Department of Health and Human ServicesHRSA HEADQUARTERS | 75R60219C00004 | 621991 | NATIONAL CORD BLOOD INVENTORY | $5.2M |
| Sep 16, 2021 | Department of Health and Human ServicesNIH NCI | 75N91021F00003 | 541714 | TASK ORDER TITLE: EVALUATION OF REAL-TIME METABOLIC IMAGING BIOMARKERS FOR DETECTION OF PANCREATIC PREMALIGNANT LESIONS | $1.2M |
| Sep 13, 2021 | Department of Health and Human ServicesNIH NCI | 75N91021F00002 | 541714 | TARGETING STAT3 TO PREVENT COLORECTAL CANCER SECONDARY TO INFLAMMATORY BOWEL DISEASE | $933K |
| Sep 8, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98021F00001 | 112990 | SQUIRREL MONKEY, BOLIVIAN, EITHER GENDER, GREATER THAN 750 GRAM, SPF, IAW RFQ N60 (MD ANDERSON 75N98021D00018) | $32K |
| Sep 8, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98021F00002 | 112990 | PER DIEM AND TESTING OF THE NIAID OWL MONKEY COLONY (MD ANDERSON 75N98021D00018) | $90K |
| Sep 2, 2021 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40121P00534 | 112990 | MERKELOMV-AP STUDY (BABOONS) | $225K |
| Aug 30, 2021 | Department of Health and Human ServicesNIH NCI | HHSN26100007 | 541712 | IGF::OT::IGF EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATION | $3K |
| Jul 14, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NLM | 75N97021C00001 | 541940 | OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | $800K |
| Jul 13, 2021 | Department of Health and Human ServicesNIH NCI | 75N91020F00002 | 541714 | TASK ORDER: PRECLINICAL TESTING OF CD73 INHIBITORS FOR PANCREATIC CANCER IMMUNOPREVENTION | $802K |
| Jun 7, 2021 | Department of Health and Human ServicesNIH NCI | 75N91019F00129 | 541712 | OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH | $322K |
| May 11, 2021 | Department of Health and Human ServicesNIH NCI | 75N91021F00001 | 541714 | PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS; TASK ORDER: PREVENTION OF COLORECTAL CANCER WITH IPSC-BASED VACCINE | $636K |
| Apr 26, 2021 | Department of Health and Human ServicesNIH NCI | HHSN26100003 | 541712 | IGF::OT::IGF A PHASE IB BIOMARKER TRIAL OF NAPROXEN IN PATIENTS AT RISK FOR DNA MISMATCH REPAIR DEFICIENT COLORECTAL CANCER (MDA2013-01-02) | $40K |
| Jan 29, 2021 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018320P0543 | 813920 | RADIOLOGICAL PHYSICS CENTER QUALITY AUDIT PROGRAM | $3K |
| Jan 19, 2021 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018320P0544 | 611310 | IROC QUALITY AUDIT PROGRAM | $750 |
| Nov 30, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NLM | 75N97021C00001 | 541940 | OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | $1.0M |
| Sep 25, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00006 | 112990 | PER DIEM, AND TESTING OF THE NIAID OWL NHP COLONY | $85K |
| Sep 25, 2020 | Department of Health and Human ServicesHRSA HEADQUARTERS | 75R60219C00004 | 621991 | NATIONAL CORD BLOOD INVENTORY | $7.8M |
| Sep 23, 2020 | Department of Health and Human ServicesNIH NCI | 75N91018F00009 | 541711 | RANK LIGAND INHIBITION - A POTENTIAL CHEMOPREVENTION STRATEGY FOR WOMEN AT HIGH GENETIC RISK OF BREAST CANCER HHSN2612015000181 TO: HHSN26100008 PP: 9/17/18 TO 3/16/2021 | $206K |
| Sep 15, 2020 | Department of Health and Human ServicesNIH NCI | 75N91020F00002 | 541714 | TASK ORDER: PRECLINICAL TESTING OF CD73 INHIBITORS FOR PANCREATIC CANCER IMMUNOPREVENTION | $389K |
| Sep 8, 2020 | Department of Health and Human ServicesNIH NCI | HHSN26100008 | 541712 | IGF::OT::IGF ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL | $13K |
| Sep 1, 2020 | Department of Health and Human ServicesNIH NCI | HHSN26100011 | 541712 | IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMOGRAPHICALLY DENSE BREASTS | $96K |
| Aug 31, 2020 | Department of Health and Human ServicesNIH NCI | HHSN26100012 | 541712 | IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER | $106K |
| Aug 17, 2020 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40120P00519 | 112990 | DURATION OF PERTUSSIS IMMUNITY IN BABOONS STUDY | $231K |
| Aug 4, 2020 | Department of Health and Human ServicesNIH NCI | 75N91019F00129 | 541712 | OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH | $566K |
| Jul 30, 2020 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40120P00459 | 112990 | BORDETELLA-FREE BABOONS | $173K |
| Jul 28, 2020 | Department of Health and Human ServicesNIH NCI | 75N91020P00681 | 611310 | MD ANDERSON CANCER CENTER:1109568 [20-032186] DNA SAMPLES FOR A GENOME-WIDE ASSOCIATION STUDY OF LYMPHOID MALIGNANCIES | $25K |
| May 8, 2020 | Department of Veterans Affairs256-NETWORK CONTRACT OFFICE 16 (36C256) | 36C25620P0876 | 541690 | RATIFICATION | $590 |
| May 8, 2020 | Department of Veterans Affairs256-NETWORK CONTRACT OFFICE 16 (36C256) | 36C25620P0879 | 541690 | RATIFICATION | $590 |
| May 8, 2020 | Department of Veterans Affairs256-NETWORK CONTRACT OFFICE 16 (36C256) | 36C25620P0912 | 541690 | RATIFICATION | $900 |
| May 8, 2020 | Department of Health and Human ServicesNIH NCI | 75N91020F00001 | 541714 | BASE:PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY&INTERMEDIATE BIOMARKERS TASK ORDER: TARGETING STAT3 TO PREVENT HEPATOCELLULAR CARCINOMA (HCC) ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) | $843K |
| Mar 20, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00005 | 112990 | LIVE ANIMALS, NOT RAISED FOR FOOD. | $51K |
| Mar 19, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00004 | 112990 | SQUIRREL MONKEY, GUYANESE ORIGIN, ADULT, EITHER GENDER, SPFIAW WITH CONTRACT SOW AND AS NOTED IN RFP RM24 | $51K |
| Dec 18, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00002 | 112990 | PER DIEM AND TESTING TO SUPPORT THE NIAID AOTUS GRISEIMEMBRA COLONY (263201600013I) | $81K |
Get Alerted Before The Univeristy Of Texas M.d. Anderson Cancer Center's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free